back to top
- TARGETing Genetic Drivers of MPN at Single Cell ResolutionJuly 25, 2019 | September-October 2019, Volume 16, Issue 5
Drs. Straube and Lane discuss TARGET-seq, an innovative method that increases single-cell RNA sequencing library complexity, simultaneously characterizing the genotype and phenotype of a heterogeneous population of cancer cells, to help understand the evolution of disease progression.
- Piecing Together the Bone Marrow NicheMay 22, 2019 | July-August 2019, Volume 16, Issue 4
Dr. Ling and Dr. Lane discuss a study that helps piece together the complex, three-dimensional, living jigsaw puzzle that is the bone marrow hematopoietic stem cell niche.
- Unraveling the Loops of Drug Resistance in ALLApril 10, 2019 | May-June 2019, Volume 16, Issue 3
Dr. Lane discusses results of a study observing the link between tissue specificity of glucocorticoid response and acquired glucocorticoid resistance in acute lymphoblastic leukemia.
- Beating AML: Know Your EnemyFebruary 20, 2019 | March-April 2019, Volume 16, Issue 2
Dr. Lane stresses the importance of understanding disease, in this case acute myeloid leukemia, and discusses results of the Beat AML Trial.
Dr. Lane is Head of the Cancer Program at QIMR Berghofer Medical Research Institute and a clinical hematologist at Royal Brisbane and Women's Hospital.